![Paul Hannewald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Hannewald
Director/Miembro de la Junta en PLANT ADVANCED TECHNOLOGIES .
Perfil
Paul Hannewald is currently the Director at Plant Advanced Technologies SA, the Manager at Newland SCI, and the Manager at Pharmacie de Chantraine.
Previously, he served as the Chairman at StratiCELL SA and as the Managing Director & Operational Director at Temisis Therapeutics SA.
Cargos activos de Paul Hannewald
| Empresas | Cargo | Inicio |
|---|---|---|
| PLANT ADVANCED TECHNOLOGIES | Director/Miembro de la Junta | 01/01/2010 |
Newland SCI | Corporate Officer/Principal | 24/06/2021 |
Antiguos cargos conocidos de Paul Hannewald.
| Empresas | Cargo | Fin |
|---|---|---|
Temisis Therapeutics SA | Director Ejecutivo | 01/12/2021 |
StratiCELL SA
 StratiCELL SA Miscellaneous Commercial ServicesCommercial Services StratiCELL SA provides vitro testing services. Its dermo cosmetic testing services include gene expression profiling, in virto bioassays, safety and dermal toxicology, percutaneous absorption and customized research and development partnership. The company was founded by Michel Salmon and Olivier Toussaint in 2005 and is headquartered in Les Isnes, WA. | Presidente | 20/04/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PLANT ADVANCED TECHNOLOGIES | Process Industries |
| Empresas privadas | 3 |
|---|---|
StratiCELL SA
StratiCELL SA Miscellaneous Commercial ServicesCommercial Services StratiCELL SA provides vitro testing services. Its dermo cosmetic testing services include gene expression profiling, in virto bioassays, safety and dermal toxicology, percutaneous absorption and customized research and development partnership. The company was founded by Michel Salmon and Olivier Toussaint in 2005 and is headquartered in Les Isnes, WA. | Commercial Services |
Temisis Therapeutics SA | |
Newland SCI |
- Bolsa de valores
- Insiders
- Paul Hannewald
